| [9] |
Ronco C. Endotoxin removal: history of a mission [J]. Blood Purif, 2014, 37(Suppl 1): 5-8.
|
| [10] |
Rimmele T, Kaynar AM, McLaughlin JN, et al. Leukocyte capture and modulation of cell-mediated immunity during human sepsis: an ex vivo study [J]. Crit Care, 2013, 17(2): R59.
|
| [11] |
Kellum JA, Johnson JP, Kramer D, et al. Diffusive vs convective therapy: effects on mediators of inflammation in patient with severe systemic inflammatory response syndrome [J]. Crit Care Med, 1998, 26(12): 1995-2000.
|
| [12] |
Rimmele T, Wey PF, Bernard N, et al. Hemofiltration with the Cascade system in an experimental porcine model of septic shock [J]. Ther Apher Dial, 2009, 13(1): 63-70.
|
| [13] |
Morgera S, Haase M, Kuss T, et al. Pilot study on the effects of high cutoff hemofiltration on the need for norepinephrine in septic patients with acute renal failure [J]. Crit Care Med, 2006, 34(8): 2099-2104.
|
| [14] |
Gruda MC, Ruggeberg KG, O′Sullivan P, et al. Broad adsorption of sepsis-related PAMP and DAMP molecules, mycotoxins, and cytokines from whole blood using CytoSorb(R) sorbent porous polymer beads [J]. PLoS One, 2018, 13(1): e0191676.
|
| [15] |
Sakai Y. Polymethylmethacrylate membrane with a series of serendipity [J]. Contrib Nephrol, 2011, 173: 137-147.
|
| [16] |
Payen D. Haemoperfusion with polymyxin B membrane: recent results for an old debate! [J]. Anaesth Crit Care Pain Med, 2019, 38(1): 3-4.
|
| [17] |
Adamik B, Zielinski S, Smiechowicz J, et al. Endotoxin elimination in patients with septic shock: an observation study [J]. Arch Immunol Ther Exp (Warsz), 2015, 63(6): 475-483.
|
| [18] |
Rogiers P, Zhang H, Pauwels D, et al. Comparison of polyacrylonitrile (AN69) and polysulphone membrane during hemofiltration in canine endotoxic shock [J]. Crit Care Med, 2003, 31(4): 1219-1225.
|
| [19] |
Renaux JL, Thomas M, Crost T, et al. Activation of the kallikrein-kinin system in hemodialysis: role of membrane electronegativity, blood dilution, and pH [J]. Kidney Int, 1999, 55(3): 1097-1103.
|
| [20] |
Chanard J, Lavaud S, Maheut H, et al. The clinical evaluation of low-dose heparin in haemodialysis: a prospective study using the heparin-coated AN69 ST membrane [J]. Nephrol Dial Transplant, 2008, 23(6): 2003-2009.
|
| [21] |
Yumoto M, Nishida O, Moriyama K, et al. In vitro evaluation of high mobility group box 1 protein removal with various membranes for continuous hemofiltration [J]. Ther Apher Dial, 2011, 15(4): 385-393.
|
| [22] |
Kobashi S, Maruhashi T, Nakamura T, et al. The 28-day survival rates of two cytokine-adsorbing hemofilters for continuous renal replacement therapy: a single-center retrospective comparative study [J]. Acute Med Surg, 2019, 6(1): 60-67.
|
| [23] |
Malard B, Lambert C, Kellum JA. In vitro comparison of the adsorption of inflammatory mediators by blood purification devices [J]. Intensive Care Med Exp, 2018, 6(1): 12.
|
| [24] |
Laville M, Dorval M, Fort Ros J, et al. Results of the HepZero study comparing heparin-grafted membrane and standard care show that heparin-grafted dialyzer is safe and easy to use for heparin-free dialysis [J]. Kidney Int, 2014, 86(6): 1260-1267.
|
| [25] |
Kessler M, Gangemi C, Gutierrez Martones A, et al. Heparin-grafted dialysis membrane allows minimal systemic anticoagulation in regular hemodialysis patients: a prospective proof-of-concept study [J]. Hemodial Int, 2013, 17(2): 282-293.
|
| [26] |
Shum HP, Chan KC, Kwan MC, et al. Application of endotoxin and cytokine adsorption haemofilter in septic acute kidney injury due to Gram-negative bacterial infection [J]. Hong Kong Med J, 2013, 19(6): 491-497.
|
| [27] |
Tian Q, Gomersall CD, Ip M, et al. Adsorption of amikacin, a significant mechanism of elimination by hemofiltration [J]. Antimicrob Agents Chemother, 2008, 52(3): 1009-1013.
|
| [28] |
De Vriese AS, Colardyn FA, Philippe JJ, et al. Cytokine removal during continuous hemofiltration in septic patients [J]. J Am Soc Nephrol, 1999, 10(4): 846-853.
|
| [29] |
McCrea K, Ward R, LaRosa SP. Removal of carbapenem-resistant Enterobacteriaceae (CRE) from blood by heparin-functional hemoperfusion media [J]. PLoS One, 2014, 9(12): e114242.
|
| [30] |
Kang JH, Super M, Yung CW, et al. An extracorporeal blood-cleansing device for sepsis therapy [J]. Nat Med, 2014, 20(10): 1211-1216.
|
| [31] |
Buttner S, Koch B, Dolnik O, et al. Extracorporeal virus elimination for the treatment of severe Ebola virus disease--first experience with lectin affinity plasmapheresis [J]. Blood Purif, 2014, 38(3-4): 286-291.
|
| [32] |
Pino CJ, Yevzlin AS, Tumlin J, et al. Cell-based strategies for the treatment of kidney dysfunction: a review [J]. Blood Purif, 2012, 34(2): 117-123.
|
| [33] |
Pino CJ, Yevzlin AS, Lee K, et al. Cell-based approaches for the treatment of systemic inflammation [J]. Nephrol Dial Transplant, 2013, 28(2): 296-302.
|
| [34] |
Ding F, Song JH, Jung JY, et al. A biomimetic membrane device that modulates the excessive inflammatory response to sepsis [J]. PLoS One, 2011, 6(4): e18584.
|
| [35] |
Srisawat N, Tungsanga S, Lumlertgul N, et al. The effect of polymyxin B hemoperfusion on modulation of human leukocyte antigen DR in severe sepsis patients [J]. Crit Care, 2018, 22(1): 279.
|
| [36] |
Gossez M, Rimmele T, Andrieu T, et al. Proof of concept study of mass cytometry in septic shock patients reveals novel immune alterations [J]. Sci Rep, 2018, 8(1): 17296.
|
| [1] |
Singer M, Deutschman CS, Seymour CW, et al. The third international consensus definitions for sepsis and septic shock (Sepsis-3) [J]. JAMA, 2016, 315(8): 801-810.
|
| [2] |
Shankar-Hari M, Deutschman CS, Singer M. Do we need a new definition of sepsis? [J]. Intensive Care Med, 2015, 41(5): 909-911.
|
| [3] |
Ankawi G, Neri M, Zhang J, et al. Extracorporeal techniques for the treatment of critically ill patients with sepsis beyond conventional blood purification therapy: the promises and the pitfalls [J]. Crit Care, 2018, 22(1): 262.
|
| [4] |
Zarbock A, Gomez H, Kellum JA. Sepsis-induced acute kidney injury revisited: pathophysiology, prevention and future therapies [J]. Curr Opin Crit Care, 2014, 20(6): 588-595.
|
| [5] |
Ronco C, Tetta C, Mariano F, et al. Interpreting the mechanisms of continuous renal replacement therapy in sepsis: the peak concentration hypothesis [J]. Artif Organs, 2003, 27(9): 792-801.
|
| [6] |
Bhatia M, Moochhala S. Role of inflammatory mediators in the pathophysiology of acute respiratory distress syndrome [J]. J Pathol, 2004, 202(2): 145-156.
|
| [7] |
Marshall JC, Foster D, Vincent JL, et al. Diagnostic and prognostic implications of endotoxemia in critical illness: results of the MEDIC study [J]. J Infect Dis, 2004, 190(3): 527-534.
|
| [8] |
Peng ZY, Wang HZ, Carter MJ, et al. Acute removal of common sepsis mediators does not explain the effects of extracorporeal blood purification in experimental sepsis [J]. Kidney Int, 2012, 81(4): 363-369.
|